Cannabinoids have established themselves as therapeutic options in the treatment of pain in recent years. Nevertheless, patients can experience problems when using them, particularly with regard to tolerance. A new aqueous nanodispersion appears to be able to eliminate these problems.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
Related Topics
You May Also Like
- Viloxazine for ADHD
A non-stimulating option—but with limited evidence
- Preclinical study on phytotherapeutic agent
Active ingredient combination of peppermint and caraway oil modified fecal microbiota
- Casuistry
Rituximab used effectively against IgG4-RD colitis
- Sarcoidosis
New options from JAKi to mTOR
- Head and neck squamous cell carcinoma
Precision immunotherapy and local treatment
- From symptom to diagnosis
Abdominal pain – Prostate cysts
- Multimodal Parkinson's Treatment
Positive Effects of a Music-Based Intervention
- Psychooncology